Results 121 to 130 of about 58,308 (290)
Long‐term efficacy of adjunctive cenobamate: Open‐label extension of a randomized, placebo‐controlled study in a multinational Asian population
Epilepsia, EarlyView.Long‐term efficacy and safety of adjunctive cenobamate in a multinational Asian population. Open‐label extension (OLE) efficacy population included all patients who had taken ≥1 dose of study drug and had any seizure data during the OLE maintenance phase.Sang Kun Lee, Peimin Yu, Eunyeong Choe, Louis Ferrari, Kyoung Heo, Seung Bong Hong, Zhen Hong, Koji Iida, Yong Heui Jeon, Jiwon Jung, Marc Kamin, Kensuke Kawai, Ji Hyun Kim, Myung Won Kim, Xiaorong Liu, Jungshin Park, William Rosenfeld, Takamichi Yamamoto, Dong Zhou, Suiqiang Zhu, Sunita N. Misra +20 morewiley +1 more sourceClassifying seizures in practice: Testing the 2025 ILAE framework among clinicians in South Africa
Epilepsia, EarlyView.Abstract Objective
The 2025 International League Against Epilepsy (ILAE) seizure classification introduced a basic version for nonspecialists, but its usability is untested. We evaluated whether a multidisciplinary frontline workforce in South Africa could apply it, how consistently, and whether performance improved after self‐directed exposure ...Aayesha J. Soni, Sarah Jacobs, Muhammad Ilyaas Amien, Abdullah J. Soni, Faeeza Cassim, Sa'ad Lahri, Naeem Brey, Misha Janse van Rensburg, Avumile Nongogo Futwa, Johnre Els, Keashe Adams, Bilal Irfan, M. Claudia Burbano, Jorge G. Burneo +13 morewiley +1 more sourceBeyond seizure control: Non–seizure‐related outcomes in focal‐onset epilepsy treated with adjunctive cenobamate. Third interim results from the BLESS study
Epilepsia, EarlyView.Abstract Objective
Cenobamate is approved for treatment of focal seizures in adults, but evidence on non‐seizure outcomes remains limited. This interim statistical analysis of the cenoBamate in aduLts with focal‐onsEt SeizureS (BLESS) study evaluated patient‐ and clinician‐reported outcomes for up to 52 weeks of cenobamate treatment.Simona Lattanzi, Giuseppe d'Orsi, Maria Teresa Di Claudio, Alfredo D'Aniello, Stefano Luca Sensi, Fedele Dono, Mariangela Panebianco, Luigi Sicurella, Alessandra Di Liberto, Andrea Novara, Carlo Di Bonaventura, Paolo Bonanni, Claudio Liguori, Federica Ranzato, Antonio Gambardella, Francesca Bisulli, Patrizia Pulitano, Giada Pauletto, Elena Tartara, Giampaolo Vatti, Giovanni Assenza, Alfonso Giordano, Anna Elisabetta Vaudano, Gionathan Mazza, Angela La Neve, Pietro Pignatta, Simone Beretta, Marianna Pezzella, Michela Cecconi, Chiara Pizzanelli, Vincenzo Andreone, Catello Vollono, Monica Puligheddu, Massimo Gangitano, Daniela Audenino, Nicoletta Foschi, Elisa Fallica, Giovanni Boero, David Stokelj, Maria Pia Pasolini, Luciana Tramacere, Gionata Strigaro, Edoardo Ferlazzo, Tiziano Zanoni, Pietro Penza, Maurizio Elia, Stefano Quadri, Giovanni De Maria, Monica Santo Sabato, Loretta Giuliano, Rosita Galli, Angelo Labate, Filippo Dainese, Giovanni Falcicchio, Roberto De Simone, Michela Procaccini, Valentina Villano, Gabriele Camattari, Daniele Andreis, Lucia Simoni, Giancarlo Di Gennaro, on behalf of the BLESS Study Group, Cecilia Catania, Alessandra Morano, Biagio Orlando, Maria Sole Borioni, Fabrizio Giaculli, Luca Pasquale Giordano, Francesca Pia Mazzeo, Marco Belluzzo, Anna Carmen Nilo, Alessia Peretti, Diana Polo, Anna Bolzan, Giulia Lippa, Marianna Nesta, Lorenzo Ricci, Felice Altieri, Alberto Danieli, Elisa Osanni, Francesco Fortunato, Giuseppe Magro, Laura Marino, Ilaria Sammarra, Francesca Felicia Operto, Carlo Andrea Galimberti, Domenico Lomonaco, Alessia Campomori, Devis Collura, Emanuela Viglietta, Lorenzo Muccioli, Martina Soldà, Veronica Viola, Nicolò Locatelli, Francesca Simonetti, Barbara Mostacci, Roberta Coa, Antonio Valentino Saporito, Vincenzo Belcastro, Valeria Badioni, Maria Grazia Pascarella, Luciano Pellegrino, Angelina Laganà, Rosario Beccore, Orazio Pardeo, Francesco Luppino, Serena Raineri, Stefano Meletti, Niccolò Biagioli, Matteo Pugnaghi, Giada Giovannini, Simona Scolastico, Margherita Burani, Lisa Taruffi, Cecilia Zivelonghi, Umberto Aguglia, Vittoria Cianci, Roberta Cutellè, Angelo Pascarella, Laura Buttarelli, Roberto Matrullo, Davide Toraldo, Chiara Di Blasi, Valeria Sarro, Antonio Volzone, Massimo Di Giovanni, Stefano Avventura, Maria Francesca Tepedino, Andrea Latino, Antonella Morea, Nicola Pilolli, Giuseppe Pontrelli, Luigi Vetri, Giulia Fatati, Sabina Bartalini, Giulia Maccanti, Giulia Beneduce, Damiano Bruno, Giacomo Evangelista, Michelangelo Dasara, Clarissa Corniello, Stefano Consoli, Davide Liviello, Paolo Quintieri, Francesco Habetswallner, Rosaria Renna, Vincenzo Loreto, Edward Cesnik, Carla Marcialis, Martina Romozzi, Costanza Sottani, Matteo Antonucci, Alessio D'Elia, Laura Carmillo, Lavinia Vassallo, Eloise Lo Mauro, Salvatore Maria Lima, Federica Cerasa, Barbara Chiocchetti, Martina Calistri, Andrea Scalvini, Elisabetta Del Zotto, Alice Figura, Giovanni Messina, Marta Maria Tentorio, Paolo Costa, Chiara Silvestri, Elisabetta Rolla, Leandro Purin, Luca Colombo, Morgan Trevisan, Gabriele Mainini, Romano Giovanni Orofino, Matteo Impellizzeri, Maria Cristina Servalli, Paolo Paone, Sara Mazzoleni, Martina Fanella, Teresa Francavilla, Daniele Graziani, Pamela Rosettani, Sara Zagaglia, Luciana Mollo, Azzurra Biagiotti, Alessandro Alesi, Maria Teresa Di Claudio, Pierangela Riani, Fabio Iannaccone, Claudia Scarpitta, Maria Proietto, Angelo Battiato, Salvatore Dominici, Martina Guadagni, Daniela Marino, Rossella Papetti, Marzia Carlini, Lucia Farotti, Marinella Tomaselli, Stefania Pavan, Matteo Cegalin, Elisa Montalenti, Giovanni Battista Rossi, Edoardo Della Sala, Claudio Gojani, Camilla Bertolini, Edoardo Pronello, Francesca Lozza +206 morewiley +1 more sourceStatin use and risk of remote seizure after first new onset status epilepticus
Epilepsia, EarlyView.Abstract Objective
Preclinical evidence supports the role of statins as antiepileptogenic agents. In this study, we investigated the risk of remote unprovoked seizures (RS) according to the use of statin therapy in a cohort of first‐ever status epilepticus (SE) survivors. Methods
Retrospective analysis was made of adult patients (age ≥ 14 years) with a Niccolò Orlandi, Giada Giovannini, Lisa Taruffi, Margherita Burani, Jefe Laureine Ngnintedem Dontsop, Mara Malerba, Simona Scolastico, Laura Madrassi, Leonardo Affronte, Matteo Pugnaghi, Anna Elisabetta Vaudano, Simona Lattanzi, Stefano Meletti +12 morewiley +1 more sourceEtiology‐specific spectrum of epilepsy syndromes (ESSES): Widening the concept of etiology‐specific epilepsies—Report from the ILAE 2021–2025 Terminology Commission
Epilepsia, EarlyView.Abstract
A new type of epilepsy syndrome, an etiology‐specific epilepsy syndrome, was defined in 2022 in recognition of major advances in identifying the many genetic and acquired etiologies underlying the epilepsies. An etiology‐specific epilepsy syndrome refers to where a known etiology is associated with a distinctive epilepsy presentation ...Ingrid E. Scheffer, Stéphane Auvin, Francesca Bisulli, Scott Demarest, Elena Gardella, Angelina Kakooza Mwesige, Rima Nabbout, Alshimaa S. Othman, Kollencheri Puthenveettil Vinayan, Robyn Whitney, Elaine Wirrell, Hideo Yamanouchi, Ji Yeoun Yoo, Sameer M. Zuberi, J. Helen Cross, Nicola Specchio +15 morewiley +1 more source